Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arnout

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|April 1, 1996
The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopeniaJ Arnout
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Risk for thrombosis linked to the target antigen of a lupus anticoagulant?J Arnout
Thrombosis and Haemostasis|August 7, 2001
Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulantsJ Arnout
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 6, 2001
The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndromeJ Arnout
Clinical Rheumatology|March 1, 1990
Influence of the lupus anticoagulant on clotting testsJ Vermylen, J Arnout
Thrombosis and Haemostasis|June 12, 1999
Lupus anticoagulant: influence on the international normalized ratioJ Arnout, J Vermylen
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic diseaseJ Arnout, J Vermylen
Lancet (London, England)|October 15, 1994
Anticardiolipin in strokeJ Vermylen, J Arnout
The Journal of Laboratory and Clinical Medicine|July 1, 1992
Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?J Vermylen, J Arnout
Lupus|November 14, 1998
Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulantsJ Arnout, J Vermylen
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|April 1, 1996
The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopeniaJ Arnout
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Risk for thrombosis linked to the target antigen of a lupus anticoagulant?J Arnout
Thrombosis and Haemostasis|August 7, 2001
Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulantsJ Arnout
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 6, 2001
The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndromeJ Arnout
Clinical Rheumatology|March 1, 1990
Influence of the lupus anticoagulant on clotting testsJ Vermylen, J Arnout
Thrombosis and Haemostasis|June 12, 1999
Lupus anticoagulant: influence on the international normalized ratioJ Arnout, J Vermylen
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic diseaseJ Arnout, J Vermylen
Lancet (London, England)|October 15, 1994
Anticardiolipin in strokeJ Vermylen, J Arnout
The Journal of Laboratory and Clinical Medicine|July 1, 1992
Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?J Vermylen, J Arnout
Lupus|November 14, 1998
Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulantsJ Arnout, J Vermylen
Pageof 13